Abstracts tagged "arthritis management"

Abstract Number: 174 • 2019 ACR/ARP Annual Meeting
Clinical Presentation and Disease Course Evaluation of Mono- and Bilateral Knee Arthritis: Results from the Leiden Early Arthritis Clinic Cohort
Johanna M Maassen¹, Xanthe ME Matthijssen ¹, Sytske Anne Bergstra ¹ and CF Allaart ¹, ¹Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands
Background/Purpose: Patients presenting with arthritis in one or both knees propose a challenge regarding diagnosis, prognosis and treatment decisions. The aim of the current study…
Abstract Number: 1535 • 2018 ACR/ARHP Annual Meeting
Enhancing Patient Ability to Process and Use Information about Medication Risks and Benefits
Genevieve Hickey¹, Caprice Hunt¹, Molly Keebler², Delesha M. Carpenter³, Elizabeth (Blair) Solow⁴, Valerie Reyna⁵, W. Benjamin Nowell⁶, Cynthia Edmonds¹, Kimberlee O'Neill¹ and Susan J. Blalock¹, ¹Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²Center for BrainHealth, University of Texas Dallas, Dallas, TX, ³Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Asheville, NC, ⁴UT Southwestern Rheumatology, Dallas, TX, ⁵Cornell University, Ithica, NY, ⁶Global Healthy Living Foundation, Upper Nyack, NY
Background/Purpose: Guidelines for the treatment of rheumatoid arthritis (RA) underscore the importance of an early and targeted approach to control inflammation. However, patients are often…
Abstract Number: 1551 • 2018 ACR/ARHP Annual Meeting
Anti-Drug Antibodies to Certolizumab Pegol Are Assiciated with Low Drug Levels and Reduced Clinical Response at 3 Months in Patients with Inflammatory Joint Diseases
Johanna Gehin¹, Guro Løvik Goll², Silje Watterdal Syversen², David J Warren¹, Joseph Sexton³, Eldri Kvein Strand⁴, Tore Kvien⁵, Elisabeth Lie² and Nils Bolstad⁶, ¹Department of Medical Biochemistry, OUS-Radiumhospitalet, Oslo, Norway, ²Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ³Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Lillehammer Revmatismesykehus, Lillehammer, Norway, ⁵NOR-DMARD, EuroSpA Research Collaboration Network, Oslo, Norway, ⁶Department of Medical Biochemistry,, OUS-Radiumhospitalet, Oslo, Norway
Background/Purpose: Anti-drug antibodies (ADAb) to biological drugs predispose patients (pts) to low drug levels and lack of treatment response. For certolizumab pegol (CP) knowledge about…
Abstract Number: 309 • 2017 ACR/ARHP Annual Meeting
Compression Assisted Arthrocentesis and Intraarticular Injection
James Bennett¹, Tej Bhavsar¹, Romy Cabacungan², Sabeen Yaqub¹, Monthida Fangtham³, N. Suzanne Emil¹, Roderick Fields⁴, Konstantin Konstantinov⁵, Arthur Bankhurst⁶, William Hayward⁷ and Wilmer Sibbitt Jr.³, ¹Internal Medicine, Division of Rheumatology, University of New Mexico Health Sciences Center, Albuquerque, NM, ²Internal Medicine, Division of Rheumatology, University of New Mexico, Albuquerque, NM, ³Rheumatology, University of New Mexico, Albuquerque, NM, ⁴Internal Medicine/ Rheumatology, University of New Mexico School of Medicine, Albuquerque, NM, ⁵1 University Of New Mexico, University of New Mexico, Albuquerque, NM, ⁶Rheumatology, University of NM Medical Center, Albuquerque, NM, ⁷Exercise and Sport Sciences, New Mexico Highlands University, Las Vegas, NM
Background/Purpose: We hypothesized that compression assisted arthrocentesis of the knee would improve arthrocentesis fluid yields and intraarticular injection outcomes.Methods: We performed conventional arthrocentesis on 215…
Abstract Number: 1004 • 2017 ACR/ARHP Annual Meeting
Arthritis Impact at the State and County Level — United States, 2015
Kamil E. Barbour¹, Suson Moss², Janet Croft², Jennifer M. Hootman³, Louise Murphy⁴, Kristina Theis², Yan Wang², Hua Lu², Teresa J. Brady¹ and Charles G. Helmick², ¹Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²Centers for Disease Control and Prevention, Atlanta, GA, ³Centers for Disease Control and Prevention, Kennesaw, GA, ⁴Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Arthritis, a leading cause of disability, affects 54.4 million US adults. By knowing the state and county level arthritis impact, state-level public health professionals…
Abstract Number: 1955 • 2017 ACR/ARHP Annual Meeting
Health Care Provider Advice for Weight Loss Among US Adults with Arthritis, National Health Interview Survey, 2014
Jennifer M. Hootman¹, Miriam G. Cisternas², Louise Murphy³ and Teresa J. Brady⁴, ¹Centers for Disease Control and Prevention, Kennesaw, GA, ²MGC Data Services, Carlsbad, CA, ³Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA, ⁴Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Most clinical practice guidelines for the management of osteoarthritis recommend weight loss for adults with arthritis who are overweight or obese. A health care…
Abstract Number: 2260 • 2017 ACR/ARHP Annual Meeting
Communication Strategies Are Highly Important to Avoid Nocebo Effect When Performing Non-Medical Switch from Originator Product to Biosimilar Product: Danish Results from Applying the Parker Model a Qualitative 3-Step Research Model
Tanja Schjødt Jørgensen¹, Marie Skougaard¹, Hans Christian Asmussen^2,3, Anne Lee⁴, Peter C. Taylor⁵, Henrik Gudbergsen¹ and Lars Erik Kristensen¹, ¹The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen F, Denmark, ²NATiON, Copenhagen, Denmark, ³Communication IKH, Roskilde University, Roskilde, Denmark, ⁴University of Southern Denmark, Odense, Denmark, ⁵University of Oxford Botnar Research Centre, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom
Background/Purpose: Introducing a non-medical switch from originator to a biosimilar product in the management of chronic arthritis, i.e. switching patients in remission or low disease…
Abstract Number: 2822 • 2017 ACR/ARHP Annual Meeting
A Randomized Controlled Effectiveness Trial of the Enhance-Fitness® Physical Activity Program in People with Arthritis
Dina L. Jones¹, Jennifer L. Eicher¹, Hannah M. Ludwick² and Kayéromi D. Gomez³, ¹Orthopaedics, West Virginia University, Morgantown, WV, ²Biostatistics, West Virginia University, Morgantown, WV, ³Office of Research, University of Illinois College of Medicine at Rockford, Rockford, IL
Background/Purpose: EnhanceFitness® (EF) is an evidence-based, community-delivered intervention for older adults; however, its effectiveness in people with arthritis is unknown. The purpose of this pragmatic,…
Abstract Number: 480 • 2016 ACR/ARHP Annual Meeting
Local Cryotherapy Down-Regulates Local and Systemic IL-6/IL-17 Pathway with No Effect on TNF-α in Adjuvant-Induced Arthritis
Xavier Guillot^1,2, Hélène Martin¹, Katy Maguin-Gaté¹, Stéphanie Py³, Céline Demougeot¹, Daniel Wendling⁴ and Nicolas Tordi⁵, ¹EA 4267 FDE, FHU INCREASE, Université de Bourgogne Franche-Comté, Besançon, France, ²EA 4267 FDE, FHU INCREASE, Bourgogne Franche-Comté University, Besançon, France, ³INSERM-CIC 1431, Besançon University Hospital, Besançon, France, Besançon, France, ⁴Rheumatology, Besançon university hospital, Besançon, France, ⁵EA 4267 FDE, FHU INCREASE,, Bourgogne Franche-Comté University, Besançon, France
Background/Purpose: Cryotherapy is widely and empirically used in an adjuvant and symptomatic setting in inflammatory rheumatic diseases, with a low level of evidence [1]. The aim…
Abstract Number: 1249 • 2016 ACR/ARHP Annual Meeting
“There Are Still a Lot of Things That I Need”: A Qualitative Study Exploring Opportunities to Improve the Health Outcomes of First Nations People with Arthritis Seen at an on-Reserve Outreach Rheumatology Clinic
Adalberto Loyola-Sánchez¹, Lynden Crowshoe², Tyler White³, Diane Lacaille⁴ and Cheryl Barnabe⁵, ¹Rheumatology, University of Calgary, Calgary, AB, Canada, ²Family Medicine, University of Calgary, Calgary, AB, Canada, ³Siksika Health Services, Siksika, AB, Canada, ⁴Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, ⁵Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: A rheumatology specialty clinic embedded in a primary health care clinic on a First Nations reserve was established six years ago to improve access…
Abstract Number: 1737 • 2016 ACR/ARHP Annual Meeting
Adherence to Subcutaneous Biological Therapies Among Inflammatory Arthropaty Patients from a University Hospital
Catalina Gómez-Arango¹, M. Luz García-Vivar¹, Montserrat Alonso-Diez², M. Milagros Alvarez-Lavin², Eva Galindez-Agirregoikoa³, Olaia Fernández-Berrizbeitia³, Esther Ruíz-Lucea¹, Juan María Blanco-Madrigal¹, Jose Francisco Garcia-Llorente¹, Lidia Estopiñán-Fortea³, Ignacio Torre-Salaberri⁴, Edurne Guerrero-Basterretxea³, Itziar Calvo-Zorrilla³, Amaia Bilbao-González⁵ and Natalia Rivera-García⁵, ¹Rheumatology, Rheumatology Department, Basurto University Hospital, Bilbao, Spain, ²Pharmacy Department, Basurto University Hospital, Bilbao, Spain, ³Rheumatology Department, Basurto University Hospital, Bilbao, Spain, ⁴Rheumaytology, Rheumatology Department, Basurto University Hospital, Bilbao, Spain, ⁵Research Department, Basurto University Hospital, Bilbao, Spain
Background/Purpose: Rheumatic inflammatory arthropaties such as Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Spondyloarthrities (SpA) are chronic diseases that require adequate therapies, sometimes biological drugs,…
Abstract Number: 2386 • 2015 ACR/ARHP Annual Meeting
Integrating Wearable Physical Activity Monitoring Tools into Rehabilitation Practice for Patients with Arthritis: The Healthcare Professional Perspective
Graham Macdonald¹, Jenny Leese², Catherine Backman³, Aileen Davis⁴, Anne F. Townsend⁵, J Antonio Avina-Zubieta⁶, Diane Gromala⁷ and Linda Li⁵, ¹Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, ²Rehabilitation Sciences, University of British Columbia, Vancouver, BC, Canada, ³Occup Science & OccupTherapy, University of British Columbia, Vancouver, BC, Canada, ⁴Health Care and Outcomes Rsrch, Toronto Western Research Institute, Toronto, ON, Canada, ⁵Arthritis Research Canada, Richmond, BC, Canada, ⁶Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁷Simon Fraser University, Vancouver, BC, Canada
Background/Purpose: Wearable physical activity monitoring tools can be used for goal-setting and progress-monitoring in rehabilitation programs for patients with arthritis. Little is known about the…
Abstract Number: 2496 • 2015 ACR/ARHP Annual Meeting
Telerheumatology: A Technology Not Appropriate for All
Zsolt Kulcsar^1,2, Daniel Albert³, Ellyn Ercolano⁴ and John Mecchella⁵, ¹Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²Rheumatology/Leadership Preventive Medicine Residency, Dartmouth Hitchcock Medical Center, lebanon, NH, ³Medicine/Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, ⁴Telehealth, Dartmouth Hitchcock Center For Telehealth, Lebanon, NH, ⁵Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Title: Telerheumatology: A Technology Not Appropriate For AllBackground/Purpose: Access to Rheumatology care in New Hampshire (NH) and Vermont (VT) is limited, as a large proportion…
Abstract Number: 2524 • 2015 ACR/ARHP Annual Meeting
Longterm Follow-up of Children Born to Mothers with Chronic Arthritides and Exposed to Anti-TNF Alfa Agents during Pregancy and Breastfeeding: A Case-Control Study
Rossella Reggia¹, Laura Andreoli¹, Chiara Bazzani¹, Maria Grazia Lazzaroni¹, Giovanna Mazza¹, Michele Agosti¹, Roberto Gorla², Marco Taglietti², Andrea Lojacono³, Mario Motta⁴ and Angela Tincani⁵, ¹Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, ²Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, ³Obstetrics and Gynecology, Spedali Civili and University of Brescia, Brescia, Italy, ⁴Neonatal Intensive Care Unit, University and Spedali Civili of Brescia, Brescia, Italy, ⁵Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Brescia, Italy
Background/Purpose: Anti-TNFalfa agents have been used to control disease activity of patients with Chronic Arthritides (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis) during the wash-out period…
Abstract Number: 2565 • 2015 ACR/ARHP Annual Meeting
ACPA Specific IVIG Attenuate Collagen Induced Arthritis in Mice
Shaye Kivity¹, Nina Svetliscky¹, Qusim Odeh¹, Smadar Gertel¹, Howard Amital¹, Omer Gendelman¹, Iris Barshack², Alexander Volkov², Eran Bar-Meir³, Miri Blank¹ and Yehuda Shoenfeld⁴, ¹Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, ²Sheba Medical Center, Institute of Pathology, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, ³Plastic surgeon Poria Medical Center affiliated to Faculty of medicine in the Galilee Bar-Ilan university, Poria, Israel, ⁴Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel
Background/Purpose: Administration of intravenous-immunoglobulin (IVIg) is a recognized safe and efficient immunomodulatore therapy for many autoimmune diseases. Anti-idiotypic antibody binding to pathogenic autoantibodies was proposed…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].